AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29320335 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm (physician training)
Number of subjects: 479
Study 26700803 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR) program, three times a week for 40 minutes over 4 weeks
Number of subjects: 20
Study 26700803 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 25461782 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Mood Balance (MMB)
Number of subjects: 100
Study 25461782 — intervention group
Group type: COMPARATOR
Intervention: Usual Depression Care (UDC)
Number of subjects: 100
Study 22624423 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride releasing resin-based (Heliosel F)
Number of subjects: 60
Study 22624423 — intervention group
Group type: COMPARATOR
Intervention: Glass ionomer (Fuji Triage)
Number of subjects: 60
Study 19725847 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicaval surgical technique
Number of subjects: 113
Study 19725847 — intervention group
Group type: COMPARATOR
Intervention: Standard biatrial technique
Number of subjects: 113
Study 17122448 — intervention group
Group type: COMPARATOR
Intervention: Dual ET-receptor blockade in controls
Number of subjects: 16
Study 17122448 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual ET-receptor blockade in SCI
Number of subjects: 16
Study 17122448 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective ET(A)-receptor blockade in SCI
Number of subjects: 16
Study 17122448 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-stimulated training in SCI
Number of subjects: 16
Study 16283087 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory of mind training (25 minutes per day for 5-10 days)
Number of subjects: 27
Study 16283087 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive function training (25 minutes per day for 5-10 days)
Number of subjects: 27
Study 16283087 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study 12972720 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaleplon (ZAL)
Number of subjects: 10
Study 12972720 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10
Study 10380243 — intervention group
Group type: EXPERIMENTAL
Intervention: External focus on the club swing
Number of subjects: 22
Study 10380243 — intervention group
Group type: COMPARATOR
Intervention: Internal focus on the arm swing
Number of subjects: 22
Study 8555852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) - 16 individual weekly sessions in addition to medical care
Number of subjects: 60
Study 8555852 — intervention group
Group type: COMPARATOR
Intervention: Medical care alone
Number of subjects: 60
Study 1810080 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 75 mg daily
Number of subjects: 60
Study 1810080 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 150 mg daily
Number of subjects: 60
Study 1810080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 6343815 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol powder (Ventolin, 200 micrograms) via Rotahaler (SR)
Number of subjects: 25
Study 6343815 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline sulphate (Bricanyl, 500 micrograms) via Misthaler (TM)
Number of subjects: 25
Study 6343815 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for Ventolin Rotahaler
Number of subjects: 25
Study 30528802 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense dose-dense epirubicin, paclitaxel, cyclophosphamide (iddEPC)
Number of subjects: 945
Study 30528802 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel, liposomal doxorubicin (plus carboplatin in TNBC) (PM(Cb))
Number of subjects: 945
Study 28198120 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecithinized curcumin (1 g/day for 6 weeks)
Number of subjects: 120
Study 28198120 — intervention group
Group type: EXPERIMENTAL
Intervention: Unformulated curcumin (1 g/day for 6 weeks)
Number of subjects: 120
Study 28198120 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 6 weeks)
Number of subjects: 120
Study 28198120 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 120
Study 25706743 — intervention group
Group type: EXPERIMENTAL
Intervention: Narratives acknowledging individual responsibility while emphasizing social determinants of obesity
Number of subjects: 718
Study 25706743 — intervention group
Group type: COMPARATOR
Intervention: Narratives not acknowledging individual responsibility
Number of subjects: 718
Study 24401555 — intervention group
Group type: EXPERIMENTAL
Intervention: WDYD Web-based brief alcohol intervention (single-session and fully automated)
Number of subjects: 907
Study 24401555 — intervention group
Group type: COMPARATOR
Intervention: Assessment only (control condition)
Number of subjects: 907
Study 23078651 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimobendan (Vetmedin capsules)
Number of subjects: 76
Study 23078651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 19177449 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose tacrolimus (10-15 ng/mL) plus intravenous MMF (1 g twice daily) with corticosteroids
Number of subjects: 60
Study 19177449 — intervention group
Group type: COMPARATOR
Intervention: Reduced-dose tacrolimus (5-8 ng/mL) plus intravenous MMF (1 g twice daily) with corticosteroids
Number of subjects: 60
Study 17150015 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene and cell therapies for myocardial neovascularisation
Number of subjects: 0
Study 17150015 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies
Number of subjects: 0
Study 17150015 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel imaging techniques
Number of subjects: 0
Study 15566035 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal polysaccharide vaccine
Number of subjects: 27
Study 11226121 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0
Study 11226121 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 10504080 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol epithelial removal (20% ethanol solution applied for 20 seconds)
Number of subjects: 190
Study 10504080 — intervention group
Group type: COMPARATOR
Intervention: Mechanical epithelial removal (Desmarres blade)
Number of subjects: 190
Study 8695463 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment and treatment in primary care using a trained nurse
Number of subjects: 0
Study 1654136 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (four consecutive, logarithmically increasing doses)
Number of subjects: 34
Study 1654136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 7048591 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine irrigation
Number of subjects: 592
Study 7048591 — intervention group
Group type: COMPARATOR
Intervention: Control (no irrigation)
Number of subjects: 592
Study 30629601 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval walking training (IWT) with additional support (goal-setting, ecological momentary assessment, and personalized phone-calls) for 12 weeks.
Number of subjects: 37
Study 30629601 — intervention group
Group type: COMPARATOR
Intervention: Interval walking training (IWT) without additional support for 12 weeks (control group).
Number of subjects: 37
Study 30629601 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (IWT with support)
Number of subjects: 37
Study 30629601 — intervention group
Group type: COMPARATOR
Intervention: Control group (IWT without support)
Number of subjects: 37
Study 29886354 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 30
Study 29886354 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 30
Study 27920497 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD‐828 2.5/40 mg
Number of subjects: 187
Study 27920497 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD‐828 2.5/80 mg
Number of subjects: 187
Study 27920497 — intervention group
Group type: COMPARATOR
Intervention: S‐amlodipine 2.5 mg
Number of subjects: 187
Study 24656636 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiperspirant containing aluminum chlorohydrate
Number of subjects: 52
Study 23682544 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2 at 1 atm abs (101 kPa)
Number of subjects: 12
Study 23682544 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2 at 1.5 atm abs (152 kPa)
Number of subjects: 12
Study 23682544 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2 at 2 atm abs (203 kPa)
Number of subjects: 12
Study 23682544 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2 at 1-2 atm abs
Number of subjects: 12
Study 21336439 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding (EF) on the first postoperative day
Number of subjects: 29
Study 21336439 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative dietary regimen (TRAD)
Number of subjects: 29
Study 19102361 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 28
Study 19102361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 15725174 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training in mouth care (lecture, video material, clinical demonstrations)
Number of subjects: 78
Study 15725174 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff training in mouth care
Number of subjects: 78
Study 12669122 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily subcutaneous LMWH (bemiparin) for one week (group B)
Number of subjects: 378
Study 12669122 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily bemiparin in a therapeutic dose for one week followed by a maintenance dose for 12 weeks (group C)
Number of subjects: 378
Study 12669122 — intervention group
Group type: COMPARATOR
Intervention: Intravenous unfractionated heparin (group A)
Number of subjects: 378
Study 10383514 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 219
Study 10383514 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 219
Study 10383514 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg
Number of subjects: 219
Study 8826783 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid occlusive dressing technique
Number of subjects: 44
Study 8826783 — intervention group
Group type: COMPARATOR
Intervention: Conventional wet‐to‐dry gauze dressing technique
Number of subjects: 44
Study 1384566 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive language intervention
Number of subjects: 32
Study 1384566 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (control)
Number of subjects: 32
Study 3972652 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole (up to 40 mg/kg)
Number of subjects: 34
Study 3972652 — intervention group
Group type: COMPARATOR
Intervention: CCNU (130 mg/m2)
Number of subjects: 34
Study 30858208 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline 200 mg i.v. on day 1, then 300 mg orally q24h
Number of subjects: 31
Study 30858208 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline 300 mg orally q12h on day 1, then 300 mg orally q24h
Number of subjects: 31
Study 30858208 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline 450 mg orally q12h on day 1, then 450 mg orally q24h
Number of subjects: 31
Study 30858208 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline (all groups)
Number of subjects: 31
Study 29126207 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% GWL
Number of subjects: 475
Study 29126207 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% GWL
Number of subjects: 475
Study 29126207 — intervention group
Group type: COMPARATOR
Intervention: No GWL (control)
Number of subjects: 475
Study 26540136 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (100,000 IU load plus 4,000 IU/d) for 28 weeks
Number of subjects: 408
Study 26540136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 408
Study 26540136 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D
Number of subjects: 408
Study 26540136 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D sufficiency responders
Number of subjects: 408
Study 24556755 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=24)
Number of subjects: 50
Study 24556755 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=26)
Number of subjects: 50
Study 22340605 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized Prolate Ablation (OPA)
Number of subjects: 39
Study 22340605 — intervention group
Group type: COMPARATOR
Intervention: Optical Path Difference Custom Aspheric Treatment (OPDCAT)
Number of subjects: 39
Study 22340605 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolate Ablation (OPA)
Number of subjects: 39
Study 22340605 — intervention group
Group type: COMPARATOR
Intervention: Aspheric Ablation (OPDCAT)
Number of subjects: 39
Study 20036036 — intervention group
Group type: EXPERIMENTAL
Intervention: Apex-Anterior (A-A) electrode position
Number of subjects: 91
Study 20036036 — intervention group
Group type: COMPARATOR
Intervention: Left Anteroposterior (A-P) electrode position
Number of subjects: 91
Study 17572410 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily for 6 months
Number of subjects: 75
Study 17572410 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 75
Study 15969897 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 4‐mg oral granules
Number of subjects: 0
Study 15969897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14616102 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 1079
Study 14616102 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 1079
Study 14616102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1079
Study 10572288 — intervention group
Group type: EXPERIMENTAL
Intervention: Wisconsin Card Sorting Test for malingering detection in undergraduates
Number of subjects: 105
Study 10572288 — intervention group
Group type: EXPERIMENTAL
Intervention: Wisconsin Card Sorting Test for malingering detection in brain injured patients
Number of subjects: 105
Study 8572359 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted 8 cm
Number of subjects: 800
Study 8572359 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted 2 cm
Number of subjects: 800
Study 8572359 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted > 2 cm
Number of subjects: 800
Study 8572359 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheters inserted 2 or 4 cm
Number of subjects: 800
Study 8572359 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheters resulting in unilateral sensory analgesia
Number of subjects: 800
Study 8572359 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheters resulting in intravenous cannulation
Number of subjects: 800
Study 8383088 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon-alpha 2a (50 x 10(6) IU/m2) intramuscularly three times a week (n = 35)
Number of subjects: 71
Study 8383088 — intervention group
Group type: COMPARATOR
Intervention: No antitumor therapy (n = 36)
Number of subjects: 71
Study 8383088 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon-alpha 2a
Number of subjects: 71
Study 2828458 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (100 mg)
Number of subjects: 6
Study 2828458 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 6
Study 2828458 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening protocol (20:00 h)
Number of subjects: 6
Study 29489046 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (alpha-adrenergic agonist)
Number of subjects: 93
Study 29489046 — intervention group
Group type: EXPERIMENTAL
Intervention: Covert hostility
Number of subjects: 93
Study 29489046 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD symptom severity
Number of subjects: 93
Study 29489046 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression symptoms
Number of subjects: 93
Study 27439724 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion intervention (INT) delivered by trained Navajo lay health workers, including 5 interactions for children, 4 for parents, and 4 fluoride varnish applications over 3 years.
Number of subjects: 1016
Study 27439724 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) control group, no specific intervention details provided.
Number of subjects: 1016
Study 27439724 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion intervention (INT)
Number of subjects: 1016
Study 27439724 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1016
Study 27439724 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion intervention (INT) among adherent children
Number of subjects: 1016
Study 27439724 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) among non-adherent children
Number of subjects: 1016
Study 26336931 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg)
Number of subjects: 62
Study 23506974 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice (selecting between a low-carbohydrate, calorie-unrestricted diet (LCD) or a low-fat, reduced-calorie diet (LFD))
Number of subjects: 216
Study 23506974 — intervention group
Group type: COMPARATOR
Intervention: Control (randomly assigned to follow either a low-carbohydrate, calorie-unrestricted diet (LCD) or a low-fat, reduced-calorie diet (LFD))
Number of subjects: 216
Study 23506974 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice (adherence to diet by food frequency questionnaire)
Number of subjects: 216
Study 23506974 — intervention group
Group type: COMPARATOR
Intervention: Control (adherence to diet by food frequency questionnaire)
Number of subjects: 216
Study 23506974 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice (obesity-specific health-related quality of life)
Number of subjects: 216
Study 23506974 — intervention group
Group type: COMPARATOR
Intervention: Control (obesity-specific health-related quality of life)
Number of subjects: 216
Study 21674393 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy using MIME (high-dose, 30 hours)
Number of subjects: 54
Study 21674393 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy using MIME (low-dose, 15 hours)
Number of subjects: 54
Study 21674393 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional therapy, up to 15 hours)
Number of subjects: 54
Study 18680490 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) 110 microg once daily
Number of subjects: 554
Study 18680490 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) 55 microg once daily
Number of subjects: 554
Study 18680490 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 554
Study 16919390 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate 100mM
Number of subjects: 30
Study 16919390 — intervention group
Group type: COMPARATOR
Intervention: Glutamate (various concentrations)
Number of subjects: 30
Study 16919390 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline 0.9%
Number of subjects: 30
Study 15650064 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP)
Number of subjects: 51
Study 15650064 — intervention group
Group type: COMPARATOR
Intervention: Two-stage etch and prime
Number of subjects: 51
Study 11135504 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative Program (contacts by local outreach workers, cognitive-behavioral relapse-prevention group counseling, individual counseling for needs assessment and referral)
Number of subjects: 0
Study 10433045 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-axis inverted imaging condition (experienced surgeons)
Number of subjects: 32
Study 10433045 — intervention group
Group type: COMPARATOR
Intervention: Normal imaging condition (experienced surgeons)
Number of subjects: 32
Study 10433045 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-axis inverted imaging condition (novice participants)
Number of subjects: 32
Study 10433045 — intervention group
Group type: COMPARATOR
Intervention: Normal imaging condition (novice participants)
Number of subjects: 32
Study 7924319 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu 380A IUD
Number of subjects: 0
Study 2554244 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rhesus rotavirus vaccine (RRV) with oral poliovirus vaccine (OPV)
Number of subjects: 102
Study 2554244 — intervention group
Group type: COMPARATOR
Intervention: Placebo with oral poliovirus vaccine (OPV)
Number of subjects: 102
Study 2554244 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rhesus rotavirus vaccine (RRV) 2 weeks after OPV
Number of subjects: 102
Study 239517 — intervention group
Group type: EXPERIMENTAL
Intervention: HC20‐511
Number of subjects: 42
Study 239517 — intervention group
Group type: COMPARATOR
Intervention: Dimetinden (Fenistil retard)
Number of subjects: 42
Study 29386308 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 27
Study 29386308 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 27
Study 29386308 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 27
Study 28878181 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (200 mg/day) and ARA (200 mg/day) supplement
Number of subjects: 133
Study 28878181 — intervention group
Group type: COMPARATOR
Intervention: Corn oil supplement (control)
Number of subjects: 133
Study 25043631 — intervention group
Group type: EXPERIMENTAL
Intervention: Making It Work program (5 online group sessions, 5 web-based e-learning modules, consultations with an occupational therapist and vocational rehabilitation counselor)
Number of subjects: 526
Study 25043631 — intervention group
Group type: EXPERIMENTAL
Intervention: Making It Work program
Number of subjects: 526
Study 23302714 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose control (hemoglobin A1c target 6.5% or less)
Number of subjects: 11140